125 related articles for article (PubMed ID: 9196053)
1. Transcriptional activation of the human c-myc gene by simian virus 40 large T antigen without binding to p53 and RB proteins in the transient expression system.
Shimazu T; Takada S; Ishida S; Ueno Y; Koike K
Biochem Biophys Res Commun; 1997 Jun; 235(1):153-7. PubMed ID: 9196053
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen.
Batsché E; Lipp M; Cremisi C
Oncogene; 1994 Aug; 9(8):2235-43. PubMed ID: 8036009
[TBL] [Abstract][Full Text] [Related]
3. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
Moberg KH; Tyndall WA; Hall DJ
J Cell Biochem; 1992 Jun; 49(2):208-15. PubMed ID: 1400626
[TBL] [Abstract][Full Text] [Related]
4. Efficient replication of plasmids containing the SV40 origin in N-myc overexpressing human neuroblastoma cells.
Lee NG; Yamaguchi J; Subramanian KN
Oncogene; 1991 Jul; 6(7):1161-9. PubMed ID: 1650440
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of the neu promoter by the SV40 large T antigen.
Matin A; Hung MC
Cell Growth Differ; 1993 Dec; 4(12):1051-6. PubMed ID: 7906953
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.
Nakagoshi H; Kanei-Ishii C; Sawazaki T; Mizuguchi G; Ishii S
Oncogene; 1992 Jun; 7(6):1233-40. PubMed ID: 1594249
[TBL] [Abstract][Full Text] [Related]
7. Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's limited transforming activity but does eliminate viral viability.
Tavis JE; Trowbridge PW; Frisque RJ
Virology; 1994 Mar; 199(2):384-92. PubMed ID: 8122368
[TBL] [Abstract][Full Text] [Related]
8. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins.
Ishida S; Shudo K; Takada S; Koike K
Cell Growth Differ; 1994 Mar; 5(3):287-94. PubMed ID: 8018561
[TBL] [Abstract][Full Text] [Related]
9. The retinoblastoma susceptibility gene product regulates Myc-mediated transcription.
Adnane J; Robbins PD
Oncogene; 1995 Jan; 10(2):381-7. PubMed ID: 7838535
[TBL] [Abstract][Full Text] [Related]
10. Effect of tumor suppressors on cell cycle-regulatory genes: RB suppresses p34cdc2 expression and normal p53 suppresses cyclin A expression.
Yamamoto M; Yoshida M; Ono K; Fujita T; Ohtani-Fujita N; Sakai T; Nikaido T
Exp Cell Res; 1994 Jan; 210(1):94-101. PubMed ID: 8270002
[TBL] [Abstract][Full Text] [Related]
11. Intracistronic complementation reveals a new function of SV40 T antigen that co-operates with Rb and p53 binding to stimulate DNA synthesis in quiescent cells.
Dobbelstein M; Arthur AK; Dehde S; van Zee K; Dickmanns A; Fanning E
Oncogene; 1992 May; 7(5):837-47. PubMed ID: 1570154
[TBL] [Abstract][Full Text] [Related]
12. Abrogation of p53-mediated transactivation by SV40 large T antigen.
Segawa K; Minowa A; Sugasawa K; Takano T; Hanaoka F
Oncogene; 1993 Mar; 8(3):543-8. PubMed ID: 8382354
[TBL] [Abstract][Full Text] [Related]
13. Identification of a p53-dependent negative response element in the bcl-2 gene.
Miyashita T; Harigai M; Hanada M; Reed JC
Cancer Res; 1994 Jun; 54(12):3131-5. PubMed ID: 8205530
[TBL] [Abstract][Full Text] [Related]
14. The effects of SV40 large T antigen and p53 on nuclear transport capacity in BALB/c 3T3 cells.
Feldherr C; Cole C; Lanford RE; Akin D
Exp Cell Res; 1994 Jul; 213(1):164-71. PubMed ID: 8020587
[TBL] [Abstract][Full Text] [Related]
15. An SV40 large T antigen binding site in the cellular genome is part of a cis-acting transcriptional element.
Wagner S; Knippers R
Oncogene; 1990 Mar; 5(3):353-9. PubMed ID: 2156208
[TBL] [Abstract][Full Text] [Related]
16. Cellular localization and T antigen binding of the retinoblastoma protein.
Bártek J; Vojtĕsek B; Grand RJ; Gallimore PH; Lane DP
Oncogene; 1992 Jan; 7(1):101-8. PubMed ID: 1741157
[TBL] [Abstract][Full Text] [Related]
17. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element.
Berberich SJ; Postel EH
Oncogene; 1995 Jun; 10(12):2343-7. PubMed ID: 7784082
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the c-myc P2 promoter.
Moberg KH; Tyndall WA; Pyrc J; Hall DJ
J Cell Physiol; 1991 Jul; 148(1):75-84. PubMed ID: 1860897
[TBL] [Abstract][Full Text] [Related]
19. A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product.
Huang S; Lee WH; Lee EY
Nature; 1991 Mar; 350(6314):160-2. PubMed ID: 2005966
[TBL] [Abstract][Full Text] [Related]
20. SV40 T antigen abrogates p53-mediated transcriptional activity.
Jiang D; Srinivasan A; Lozano G; Robbins PD
Oncogene; 1993 Oct; 8(10):2805-12. PubMed ID: 8378089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
